SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp rally, reinforced by Morgan Stanleys bullish coverage and optimism around Starship, Starlink and AI infrastructure, is driving attention. Traders are split between momentum and short-squeeze enthusiasm and concerns about stretched valuations, FOMO and upcoming share unlocks.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Traders are watching an expected NASA CLPS 2.0 announcement and speculating that Firefly could win additional lunar contracts. The discussion also reflects frustration that FLY is falling and lagging SpaceX, despite optimism about its production capacity and lunar mission pipeline.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Reports of a suspected plague exposure in Russia have fueled an outbreak-preparedness trade in NVAX, with traders speculating about government demand and a potential short squeeze. Others call the move speculative because Novavax has no plague vaccine, and point instead to its Sanofi-led Nuvaxovid rollout and royalty opportunity.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Pharvaris positive Phase 3 results for an oral hereditary-angioedema prevention drug have raised concern that competition could weigh on BioCrysts ORLADEYO sales and navenibart prospects, prompting a sharp selloff and bearish analyst commentary. Some traders see the threat as distant, arguing BioCrysts established product and patient-support infrastructure offer a buffer while they await pipeline data.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Discussion centers on CAN-2409s prostate-cancer trial and biomarker data, alongside Candels planned fourth-quarter 2026 BLA submission. Some traders view the immune findings and analyst upgrade as validation, while others question the filing timeline and raise concerns about management credibility, cash burn, and weak price action.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR discussion centers on whether its announced AI infrastructure projects will translate into revenue and cash flow, with uncertainty over project financing and potential dilution weighing on confidence. Bulls point to Yotta deployments and the companys contract pipeline as signs of progress, while skeptics question execution, management credibility and the lack of clear financing details.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentums breakout and fresh highs are drawing attention amid bullish analyst actions and expectations that AI data-center expansion will drive demand for optical networking, photonics and optical circuit switching. Traders are debating whether that growth justifies the sharp run-up, with bullish momentum and short-squeeze chatter countered by concerns about valuation, insider selling and a potential pullback.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs oncology pipeline is driving discussion, with traders highlighting encouraging lung-cancer results and comparing the companys prospects with Modernas cancer-vaccine success. Optimism is tempered by the halted colorectal-cancer vaccine trial and frustration that BNTX has lagged its peers.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

Discussion focuses on SQDs blockchain data infrastructure and its potential enterprise use, with traders pointing to Google Cloud and Robinhood-related integrations and growing demand from tokenization and AI. Bulls see adoption as a long-term opportunity, while skeptics question whether that activity will translate into value for the token and cite unlocks, volatility, and weak price action as risks.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

A weak U.S. jobs report has fueled hopes that the Fed will hold rates, supporting a broader market rebound, while traders remain wary of elevated Treasury yields and oil prices. The conversation also notes the Dows relative lag behind tech-led gains, with some seeing value opportunities and others warning of a broader correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$TOYO securing 150m contract while revenues last year were only 62m. 
 
Will enter this company in the upcoming days on any further sell off. 
 
12m Net income last year with with margins of 25%. 
 
This 150m contract should turn out to be up to 40m in profit over the next couple of years.

Brantley Hunter

Ross Pattershall

Husa

Abdlemjid El Kachcari

RofN

Nicholas Brady

StockTwits Web

TOYO Co., Ltd

 securing 150m contract while revenues last year were only 62m. 
 
Will enter this company in the upcoming days on any further sell off. 
 
12m Net income last year with with margins of 25%. 
 
This 150m contract should turn out to be up to 40m in profit over the next couple of years.